Back to MPT Database

MB66 Film

Plant produced anti-HIV and anti-HSV antibodies. Phase 1 clinical trial ends Q3 2018. The next generation of MB66 will include an anti-sperm human contraceptive antibody (HCA).

Development Stage:

Clinical – Phase 1 Trial (C1)

Hormonal/Non-Hormonal:

Non-Contraceptive

Delivery Route & Method:

Topical - Film - Vaginal

Mechanism of Action:

virus neutralization, mucus trapping

Developer:

  • Mapp Biopharmaceutical, Inc.

Funding:

  • DAIDS
  • Nat. Institute Allergy & Infect. Diseases (NIAID)

Back to MPT Database